2016 was a good year for clinical trials of interest to neuroophthalmologists. In this syllabus, I will discuss final or preliminary results from five treatment trials dealing with four disorders: primary pseudotumor cerebri syndrome (n=1), leber hereditary optic neuropathy (n=2), giant cell (temporal) arteritis (n=1), and optic pathway gliomas (n=1). It also is possible that preliminary or final results from one other trial for patients with leber hereditary optic neuropathy and one other trial for patients with giant cell arteritis will be published before the NANOS meeting, in which case these will be discussed in addition to what is presented in this syllabus.
Date
2017
Language
eng
Format
video/mp4
Type
Image/MovingImage
Source
2017 North American Neuro-Ophthalmology Society Annual Meeting
